Is there a role for IGF‐1 in the development of second primary cancers?
Abstract Cancer survival rates are increasing, and as a result, more cancer survivors are exposed to the risk of developing a second primary cancer (SPC). It has been hypothesized that one of the underlying mechanisms for this risk could be mediated by variations in insulin‐like growth factor‐1 (IGF...
Main Authors: | Thurkaa Shanmugalingam, Cecilia Bosco, Anne J. Ridley, Mieke Van Hemelrijck |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-11-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.871 |
Similar Items
-
The Second Primary Cancers in Patients with Prostate Cancer: An Update
by: CUI Qingpeng, et al.
Published: (2019-06-01) -
Prognostic Characteristics of Operated Breast Cancer Patients with Second Primary Lung Cancer: A Retrospective Study
by: Wang Y, et al.
Published: (2021-07-01) -
Risk of second primary colorectal cancer among colorectal cancer cases: A population-based analysis
by: Kavitha P Raj, et al.
Published: (2011-01-01) -
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016
by: Yngvar Nilssen, et al.
Published: (2020-05-01) -
Characteristics of metachronous second primary lung cancers
by: Coşkun Dogan, et al.
Published: (2019-01-01)